Voyager Therapeutics Inc.
www.voyagertherapeutics.com
Latest From Voyager Therapeutics Inc.
Partnering In Cell And Gene Therapy Is A Unique Endeavor
Industry and academic representatives shared viewpoints at Biotech Week Boston in September 2018, including what is unique about deal-making in the cell and gene field.
Axovant Hopes Gene Silence Is Golden With Benitec Pact
Just over a month after inking a Parkinson's disease gene therapy pact with the UK's Oxford BioMedica, Axovant has licensed a 'silence-and-replace' technology from Australia's Benitec to tackle a rare but potentially fatal disease, oculopharyngeal muscular dystrophy.
Appointments: New CEOs For Lundbeck, Voyager & Neos, CSOs For iTeos & Tilos
Deborah Dunsire’s appointment to lead Lundbeck tops this week’s list of new hires; Astellas, Orchard Therapeutics, Voyager Therapeutics, iTeos Therapeutics, Cevec Pharmaceuticals, Sangamo Therapeutics, Cedilla Therapeutics, Tilos Therepautics and Neos Therapeutics have also appointed new executives and directors.
AbbVie, Calico Extend Their Collaboration On Aging
The pharma and the Google spinout focused on aging are adding $1bn in funding to their 2014 collaboration, which has yielded more than two dozen preclinical candidates so far.
Company Information
- Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Synthesis Technologies, Production Processes
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Start-Up
- Parent & Subsidiaries
- Voyager Therapeutics Inc.
- Senior Management
-
Andre Turenne, Pres. & CEO
Bernard Ravina, MD, CMO
Alison Dorval, VP, Fin.
Matthew P Ottmer, COO - Contact Info
-
Voyager Therapeutics Inc.
Phone: (857) 259-5340
75 Sidney St.
Cambridge, MA 02139
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice